fda approvals in non-hodgkin lymphoma, breast cancer, gvhd, and mesothelioma
Published 5 years ago • 786 plays • Length 13:02
Download video MP4
Download video MP3
Similar videos
-
6:09
fda approvals in breast cancer and hodgkin lymphoma, 2017 sgo highlights, and more
-
10:18
fda approvals in bladder cancer and hodgkin lymphoma, breakthrough designation in aml, and more
-
9:29
fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
-
9:37
fda approvals in nhl and cinv, priority reviews in melanoma and breast cancer, and more
-
7:39
fda approvals in follicular lymphoma and gi, lung nets, snda in prostate cancer, and more
-
9:42
fda approval in lung cancer, promising findings in hodgkin lymphoma, and more
-
1:16
dr. lacasce discusses the fda approval of lenalidomide/rituximab in non-hodgkin lymphoma
-
10:23
fda approvals in hematologic malignancies, sbla accepted in multiple myeloma, and more
-
7:57
fda approvals in breast cancer and melanoma, disappointing results in hnscc, and more
-
6:48
fda approval in prostate cancer, phase iii data in breast cancer, and more
-
7:28
fda approvals in pml, nsclc, and breast cancer, priority review in dlbcl, and more
-
7:18
full fda approvals in breast cancer and lung cancer, priority reviews in all, and more
-
10:25
fda approvals in gbm, biosimilar in breast cancer and gastric/gej cancer, and biomarker assay
-
9:41
fda approvals in follicular lymphoma and prostate cancer, biosimilar is granted approval, and more
-
9:25
fda approvals in large b-cell lymphoma and melanoma, priority reviews in cscc and nsclc, and more
-
0:58
dr. karmali on fda approval of kte-c19 in non-hodgkin lymphoma
-
10:46
fda approval in all, priority reviews in cml and breast cancer, and more
-
13:36
fda approval in prostate cancer, nda submitted in cll and follicular lymphoma, and more
-
10:00
fda approval in breast cancer, review period extended in aml, 2019 aacr highlights, and more
Clip.africa.com - Privacy-policy